Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J8ZA
|
||||
Former ID |
DAP000955
|
||||
Drug Name |
Quinethazone
|
||||
Synonyms |
Aquamox; Chinetazone; Chinethazone; Chinethazonum; Hydromox; Idrokin; Quinetazona; Quinethazon; Quinethazonum; Chinetazone[DCIT]; CL 36010; Hydromox (TN); Quinetazona [INN-Spanish]; Quinethazone (aquamox); Quinethazonum [INN-Latin]; Quinethazone (JAN/INN); Quinethazone [INN:BAN:JAN]; 2-Ethyl-7-chloro-1,2,3,4-tetrahydro-4-oxochinazolin-6-sulfonamid; 7-Chloro-2-ethyl-1,2,3,4-tetrahydro-4-oxo-6-quinazolinesulfonamide; 7-Chloro-2-ethyl-1,2,3,4-tetrahydro-4-oxo-6-sulfamoylquinazoline; 7-Chloro-2-ethyl-6-sulfamoyl-1,2,3,4-tetrahydro-4-quinazolinone; 7-chloro-2-ethyl-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamide; 7-chloro-2-ethyl-4-oxo-2,3-dihydro-1H-quinazoline-6-sulfonamide
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antihypertensive Agents
|
||||
Structure |
Download2D MOL |
||||
Formula |
C10H12ClN3O3S
|
||||
InChI |
InChI=1S/C10H12ClN3O3S/c1-2-9-13-7-4-6(11)8(18(12,16)17)3-5(7)10(15)14-9/h3-4,9,13H,2H2,1H3,(H,14,15)(H2,12,16,17)
|
||||
InChIKey |
AGMMTXLNIQSRCG-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 73-49-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9549, 7784537, 7847527, 8153978, 11467078, 11468198, 11486646, 14800035, 29225299, 46507280, 47499748, 48019132, 48169593, 48243604, 48416507, 48424029, 49699269, 49855752, 56413186, 56463176, 57323335, 77472399, 85787548, 92125946, 103565930, 103870598, 103914667, 104311682, 121363617, 124801002, 125823752, 127403478, 134338229, 134972947, 137156434, 144076234, 144203917, 160964622, 170465167, 175611017, 176262168, 178103863, 178126126, 179149414, 223440822, 226642054, 250104410
|
||||
SuperDrug ATC ID |
C03BA02
|
||||
SuperDrug CAS ID |
cas=000073494
|
||||
Target and Pathway | |||||
Target(s) | Carbonic anhydrase | Target Info | Inhibitor | [536672] | |
References | |||||
Ref 538464 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 013264. | ||||
Ref 542309 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7289). | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.